Dava Stewart

Researchers found two loci, TRPM1 and ABHD2/RLBP1, with previously unrecognized associations related to the risk of age-related macular degeneration.

Using 24-hour wrist monitors, the study revealed “distinct mood-dependent effects on wrist-activity markers of circadian timekeeping.”

The drugs proved to be less costly than living without treatment, while also improving patients' life expectancies.

Researchers analyzed liver fibrosis levels in HIV, hepatitis B coinfection.

Previous studies have shown that “the gut microbiota differs in composition and diversity during the first months of life in children who later do or do not have allergic disease," but researchers who focused on immunoglobulin A prevalence made a different finding.

Patients who have either chronic idiopathic urticaria (CIU) or chronic spontaneous urticaria (CSU) who take oral corticosteroids (OCS) face a greater risk of side effects as well as higher total healthcare costs, according to a recent study.

Patients with intermediate uveitis (IU) have a high likelihood of achieving good long-term visual outcomes, but should expect a long disease course and frequent complications

Adalimumab (ADA) works well as a treatment for patients with both active and inactive uveitis whether or not they are taking an immunosuppressant (IMM); however, the median time to treatment failure (mTTF) is longer for patients with inactive uveitis taking an IMM.

AerobiKa, a vibratory positive expiratory pressure device meant to reduce mucus plugging, “did not demonstrate statistical significance in terms of improved clinical asthma score or reduced hospitalization rate.”

“While the concept of biofilms in atopic dermatitis is relatively new, antimicrobial and biofilm dispersing agents have been included in the treatment regimen for atopic dermatitis for decades," according to the study authors.

Curiouser and curiouser. Like Alice in Wonderland, when Alan Thompson, MD, first entered multiple sclerosis research, he was deeply puzzled. But he kept going deeper.

Cortical lesions in MS have clinical relevance.

It appears that 300 mg of omalizumab (Xolair/Genentech) is effective in reducing angioedema, according to the results of a new study.

Metered dose inhalers with a dose counter integrated could reduce the number of visits to emergency departments.

The authors assert that “there remains a need to identify inexpensive and non-toxic therapies that target the underlying pathophysiology of autoimmune disorders” and that “Blockade of the opioid growth factor (OGF)-OGF receptor (OGFr) pathway with low dose naltrexone (LDN) has been explored as one such therapy.”

Sudden hearing loss is a rare but real potential complication in multiple sclerosis.

Controlling blood pressure may be more important in stroke prevention in patients with non-valvular atrial fibrillation than thought.

Patients with relapsing remitting multiple sclerosis (RRMS) who have T2 spinal cord (SC) lesions detected through magnetic resonance imaging (MRI) early in the course of the disease are likely to have a worse prognosis, according to recent research.

A new tool called X-map may be useful to supplement a standard computed tomography (CT) scan, but cannot replace it in diagnosing acute cerebral infarction.

Patients with multiple sclerosis (MS) who want or need to measure their daily step-count may get the most accurate results with the waist-worn FitBit One, researchers found.

There are many ways of figuring out what stage of illness a patient with MS is experiencing and if relapse is likely. Researchers evaluated several.

The aim of the present meta-analysis was “to estimate the yield of AF detection in patients with stroke due to small and large vessel disease and in stroke patients in whom stroke etiology was not defined,” say the researchers.

Can a plant extract found in berries help treat hepatitis C virus? Spanish researchers say the flavonoid quercetin is effective in inhibiting an enzyme and interrupting the virus' replication.

Treating prison inmates for hepatitis C infection is a key to ending the spread of the disease. A UK study found treatment works best when it can be completed before a prisoner is released or transferred.

White patients are more likely to get clostridium difficile infections (CDI) in the hospital, but black people are more likely to die from CDI, according to the results of a recent retrospective analysis.

Siponimod continues to look promising for multiple sclerosis. Researchers report good results on three-year extension of BOLD study.

Criminal cyber attacks on healthcare institutions are on the rise. How can hospitals prevent them? Experts offer strategies.

Lymphopenia may identify an immunologically distinct subset of MS, researchers report.

In the past 15 years, no new topical AD treatments have been approved. Crisaborole, however, could be an efficient, safe, non-steoidal treatment option, according to the results of two recent phase III studies.

In study, GPT and GOT levels significantly decreased in the Kuan Sin Yin group as compared to the placebo group, by 29.7% and 24.4% respectively.